Acute Lung Injury Clinical Trials

4 recruiting

Acute Lung Injury Trials at a Glance

10 actively recruiting trials for acute lung injury are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Beijing, Beijing, and Bonn. Lead sponsors running acute lung injury studies include Beijing Tsinghua Chang Gung Hospital, China-Japan Friendship Hospital, and Assistance Publique - Hôpitaux de Paris.

Browse acute lung injury trials by phase

Treatments under study

About Acute Lung Injury Clinical Trials

Looking for clinical trials for Acute Lung Injury? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Lung Injury trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Lung Injury clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 2Phase 3

A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation

Acute Respiratory Distress Syndrome (ARDS)Acute Lung Injury(ALI)Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine60 enrolled1 locationNCT07342205
Recruiting

Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

Acute Lung InjuryAcute Respiratory FailureExtracorporeal Membrane Oxygenation Complication+1 more
Xenios AG20 enrolled2 locationsNCT06750536
Recruiting

Complications of the Alveolar Opening Maneuver in Children on Mechanical Ventilation

ComplicationPositive End-expiratory Pressure (PEEP)Oxygenation Index+3 more
Hospital de Alta Complejidad en Red143 enrolled1 locationNCT07233304
Recruiting
Phase 2

Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

Acute Lung InjuryAcute Respiratory Distress SyndromeAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)+1 more
Implicit Bioscience56 enrolled2 locationsNCT06513949
Recruiting
Phase 2

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

PreventionAcute Lung Injury
Fujian Medical University Union Hospital214 enrolled1 locationNCT05704166
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting

ALI/ARDS Clinical Sub-phenotyping Study

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
China-Japan Friendship Hospital1,500 enrolled1 locationNCT06123962
Recruiting

VExUS in Ards Patients and Association with AKI

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Assistance Publique - Hôpitaux de Paris120 enrolled1 locationNCT06805409
Recruiting
Not Applicable

Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Surfactant DysfunctionInfant
Medical University of Vienna14 enrolled1 locationNCT05002478
Recruiting

Albuterol for Acute Lung Injury

we will study the effect of adding aerosolized albuterol to lung recruitment maneuver during the managment of ALI due to surgical and non-surgical causes e.g acute lung injury following aspiration pneumonia , abdominal sepsis, pancreatitis, chest trauma , lobectomy,and so on
south valley university50 enrolled1 locationACTRN12613000836730